Literature DB >> 28752606

Successful multi-target therapy including rituximab and mycophenolate mofetil in anti-melanoma differentiation-associated gene 5 antibody-positive rapidly progressive interstitial lung disease with clinically amyopathic dermatomyositis.

Jumpei Hisanaga1, Takuya Kotani1, Youhei Fujiki1, Shuzo Yoshida1, Tohru Takeuchi1, Shigeki Makino1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28752606     DOI： 10.1111/1756-185X.13136

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN： 1756-1841            Impact factor:   2.454


× No keyword cloud information.
  8 in total

Review 1.  Antisynthetase syndrome: A distinct disease spectrum.

Authors:  Kun Huang; Rohit Aggarwal
Journal:  J Scleroderma Relat Disord       Date:  2020-02-18

Review 2.  Current Treatment for Myositis.

Authors:  Simone Barsotti; Ingrid E Lundberg
Journal:  Curr Treatm Opt Rheumatol       Date:  2018-09-15

Review 3.  Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review.

Authors:  Giulia Cassone; Marco Sebastiani; Caterina Vacchi; Gian Luca Erre; Carlo Salvarani; Andreina Manfredi
Journal:  Drugs Context       Date:  2021-01-15

4.  Case Report: Rapidly Progressive Interstitial Lung Disease in A Pregnant Patient With Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis.

Authors:  Cuihong Chen; Yulan Chen; Qin Huang; Qiu Hu; Xiaoping Hong
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

5.  MDA-5 dermatomyositis complicated by interstitial lung disease and cutaneous ulcers: successful treatment with corticosteroids, mycophenolate mofetil and intravenous immunoglobulin.

Authors:  Kelli Stager; Leanna Wise
Journal:  BMJ Case Rep       Date:  2020-09-30

6.  Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis: A case report.

Authors:  Yushiro Endo; Tomohiro Koga; Takahisa Suzuki; Kazusato Hara; Midori Ishida; Yuya Fujita; Sosuke Tsuji; Ayuko Takatani; Toshimasa Shimizu; Remi Sumiyoshi; Takashi Igawa; Masataka Umeda; Shoichi Fukui; Ayako Nishino; Shin-Ya Kawashiri; Naoki Iwamoto; Kunihiro Ichinose; Mami Tamai; Hideki Nakamura; Tomoki Origuchi; Masataka Kuwana; Atsushi Kawakami
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

Review 7.  New insights into the treatment of myositis.

Authors:  Stefanie Glaubitz; Rachel Zeng; Jens Schmidt
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-01-08       Impact factor: 5.346

8.  Rituximab in the Treatment of Interstitial Lung Diseases Related to Anti-Melanoma Differentiation-Associated Gene 5 Dermatomyositis: A Systematic Review.

Authors:  Chenjia He; Wenyu Li; Qibing Xie; Geng Yin
Journal:  Front Immunol       Date:  2022-01-18       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.